Cluster of Botulism among dutch tourists in Turkey, june 2008 [PDF]
In June 2008, three Dutch tourists participating in a mini-cruise in Turkey needed urgent repatriation for antitoxin treatment because of symptoms of botulism.
Ouwerkerk, M., van +2 more
core +1 more source
Capsule Summary Bruxism and sweat‐induced facial blisters can affect patients with Recessive Dystrophic Epidermolysis Bullosa (RDEB) quality of life (QoL). We present the outcomes of orofacial BTX‐A infiltrations to treat these conditions. Three patients with severe RDEB, bruxism and microstomia received BTX‐A infiltrations (50U‐100U) in masseters and ...
Susanne Krämer +4 more
wiley +1 more source
Challenging the Clostridium botulinum toxin type A (BoNT/A) with a selection of microorganisms by culture methods and extended storage of used vials to assess the loss of sterility [PDF]
In 2002, botulinum toxin type A (BoNT/A) was approved by the US Food and Drug Administration (FDA) for cosmetic use. However, there may be procedural differences between the ways in which a clinician handles, applies and stores the product compared to ...
Crean, Stjohn +4 more
core
The light chain of tetanus toxin inhibits calcium-dependent vasopressin release from permeabilized nerve endings [PDF]
The effects of tetanus toxin and its light and heavy chain subunits on vasopressin release were investigated in digitonin-permeabilized neurosecretory nerve terminals isolated from the neural lobe of the rat pituitary gland.
Ahnert-Hilger, G. +5 more
core +1 more source
Trends in Laryngology Fellowship Training: A Survey Study of Graduates and Directors
A survey study of laryngology fellowship Graduates and Directors reveals overall high level of confidence in preparedness to practice in the care of most laryngologic disorders. Respondents reported less exposure to swallowing disorders in fellowship with resulting lower confidence to practice independently in this area, despite seeing a good ...
Vanessa Torrecillas +4 more
wiley +1 more source
Botulinum toxin type A for painful diabetic neuropathy: an open-label study
Background A large proportion of painful diabetic neuropathy cases either do not respond or are intolerant to the currently available oral and physical therapies.
Shahinaz Helmy +2 more
doaj +1 more source
Botulinum toxin therapy: functional silencing of salivary disorders. [PDF]
Botulinum toxin (BTX) is a neurotoxic protein produced by Clostridium botulinum, an anaerobic bacterium. BTX therapy is a safe and effective treatment when used for functional silencing of the salivary glands in disorders such as sialoceles and salivary ...
Lovato, A +4 more
core
A Drosophila Model for Clostridium difficile Toxin CDT Reveals Interactions with Multiple Effector Pathways. [PDF]
Clostridium difficile infections (CDIs) cause severe and occasionally life-threatening diarrhea. Hyper-virulent strains produce CDT, a toxin that ADP-ribosylates actin monomers and inhibits actin polymerization.
Bier, Ethan +4 more
core
How I Do It: The Transtracheal Approach for Awake Cricopharyngeal Botulinum Toxin Injection
This transtracheal technique for cricopharyngeal botulinum toxin injection is a safe and effective option for chemodenervation of this muscle in the awake patient. Its advantages include reduced risk of toxin spread to intrinsic laryngeal muscles, the ability to administer higher doses of botulinum toxin, improved access to the entire length of the ...
Andrew Tritter +2 more
wiley +1 more source
BOTOX injection to treat strabismus after infant botulism type B infection
Purpose: The significance of botulinum toxin to ophthalmologists is twofold. Botulism, a medical emergency, frequently presents with ocular findings including blurred vision, diplopia, ptosis, and photophobia as a result of the neurotoxin produced by ...
Sarah G. Bonaffini +2 more
doaj +1 more source

